The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metforminPavlo Petakh, Oleksandr Kamyshnyi, Valentyn Oksenych|Biomedicine & Pharmacotherapy|2023Cited by 70
Modulating Nitric Oxide: Implications for Cytotoxicity and CytoprotectionИ. Ф. Беленичев, Oleksandr Kamyshnyi, Olena Popazova et al.|Antioxidants|2024Cited by 64
Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based InterventionsIryna Halabitska, Oleksandr Kamyshnyi, Л. С. Бабинец et al.|Biomedicines|2024Cited by 51
Current treatment options for leptospirosis: a mini-reviewPavlo Petakh, Oleksandr Kamyshnyi, Payam Behzadi et al.|Frontiers in Microbiology|2024Cited by 48
The interplay of gut microbiota, obesity, and depression: insights and interventionsIryna Halabitska, Oleksandr Kamyshnyi, Pavlo Petakh et al.|Cellular and Molecular Life Sciences|2024Cited by 40